loyon: THE SAFE & MIlD PSoRIASIS KERATolyTIC · 2018-07-18 · PSoRIASIS KERATolyTIC 0844 415 2420...

4
140513_Loyon_0003_Anz_DR.indd 1 13.05.14 14:54 LOYON: THE SAFE & MILD PSORIASIS KERATOLYTIC 0844 415 2420 [email protected] www.purpleorchidpharma.com www.loyon.co.uk 95% of responding patients successfully treated within 7 days Non-toxic, non-sticky, odourless, as effective as 10% salicylic acid Loosens plaques fast, suitable for all patients without side effects

Transcript of loyon: THE SAFE & MIlD PSoRIASIS KERATolyTIC · 2018-07-18 · PSoRIASIS KERATolyTIC 0844 415 2420...

Page 1: loyon: THE SAFE & MIlD PSoRIASIS KERATolyTIC · 2018-07-18 · PSoRIASIS KERATolyTIC 0844 415 2420 info@purpleorchidpharma.com 95% of responding patients successfully treated within

140513_Loyon_0003_Anz_DR.indd 1 13.05.14 14:54

loyon: THE SAFE & MIlD PSoRIASIS KERATolyTIC

0844 415 2420

[email protected]

www.loyon.co.uk

95% of responding patients successfully treated within 7 days

Non-toxic, non-sticky, odourless, as effective

as 10% salicylic acid

Loosens plaques fast, suitable for all patients

without side effects

Page 2: loyon: THE SAFE & MIlD PSoRIASIS KERATolyTIC · 2018-07-18 · PSoRIASIS KERATolyTIC 0844 415 2420 info@purpleorchidpharma.com 95% of responding patients successfully treated within

InnovATIvE: loyonA SAFE AnD SIMPlE nEw wAy To REMovE PlAquES

1 LOYON seeps between the crusty cells

(corneocytes) that make up the plaques. The combination of dimethicones and dicaprylyl carbonate – both stable ingredients with a long-standing

safety record - in its mild, non-toxic formula give it special creeping and spreading properties so it flows exceptionally effectively into spaces between corneocytes.

3 Plaque cells are removed easily

without bloody tear points which would create a risk of in-fection, and the skin is ready for the next stage of treatment,

such as steroids or phototherapy. Generally Loyon

only needs to be used for a few days.

2 A small amount of LOYON spreads a

long way so as it fills the spaces, it loosens the connections between

corneocytes so that these cells become free and fall away.

Key benefits:• Fast acting – great results within days• As effective as 10% salicylic acid in a study on psoriasis capitis• Easy removal of plaques without bleeding and risk of infection• No negative effects such as burning or intoxication • Mild formula is very well tolerated • Purely physical action - special creeping and spreading properties loosens plaques

• Non-toxic, works with concomitant treatments• No safety concerns in infants, the elderly, or people with impaired liver or kidney function• Economical – use one third of the amount of salicylic acid• Has a soothing effect which reduces urge to scratch• Excellent cosmetic acceptance• Two applicators for use on different areas – dropper and spray

Page 3: loyon: THE SAFE & MIlD PSoRIASIS KERATolyTIC · 2018-07-18 · PSoRIASIS KERATolyTIC 0844 415 2420 info@purpleorchidpharma.com 95% of responding patients successfully treated within

IMPRESSIvE: loyon93% oF DERMATologISTS SuRvEyED woulD RECoMMEnD IT

The pie chart shows the exceptionally high satisfaction rate of 446 dermatologists who were surveyed after 1,605 patients had used LOYON .An impressive 88.3% of doctors

responded that they were very satisfied or satisfied with the course of treatment.That’s why 92.6% of them said that

they would recommend LOYON to other patients.

These photos taken during a clinical trial tell their own story.LOYON’S innovative and purely

physical mode of action for the removal of psoriasis and cradle cap plaques delivers dramatic results. Unusually, this non-toxic, odour-

less and non-sticky formula has no side effects and can be used on all patients – even babies with cradle cap and elderly people with liver or kidney dysfunction.

LOYON was born from a need. A review of treatments1 concluded: “There is still a need for keratolytic alternatives to salicylic acid with less potential for adverse effects.”LOYON fills that gap with its fast-

acting formula, which has been shown to be as effective as 10% salicylic acid2 on scalp psoriasis.Another clinical trial3 has shown

that 95% of responding psoriasis pa-tients were successfully treated in less than seven days.Three out of four patients had treat-

ment success in just five days; 26%

of responding patients had scales assessed as severe, and after three days that was 0%. LOYON® creeps and spreads

extremely well between crusty corneocytes, so that the links between them are loosened and the individual cells fall away.Since there are no safety con-

cerns with its two stable ingredients, dimethicones and dicaprylyl carbon-ate, it is suitable for those whom the

traditional treatment of salicylic acid is inappropriate.

By clearing the plaques, LOYON® prepares the skin for the next stage of treatment, such as topical steroids, phototherapy or calcipotriol.Oils, especially olive oil4 used for

cradle cap, can damage the barrier function of the skin, but LOYON does not – is very well tolerated even on sensitive skin and has a soothing and moisturising effect.

It’s not just doctors who were happy with the way that LOYON treated psoriasis – in the same survey as above, 87.1% of patients said they were very satisfied or satisfied with it.And that’s why 86.2% of them said that

they would use it again.The survey was conducted between June

and November 2014 in Germany, with a max-imum of four patients per doctor.

Question addressed to the dermatologist:How satisfied are you with the course of the therapy?

very satisfied satisfied less satisfied not satisfied

• First results, dermatologists

LOYON® survey• First results, dermatologists

LOYON® survey

• First results, dermatologists

LOYON® survey

• First results, dermatologists

LOYON® survey1.9

• First results, dermatologists

LOYON® survey

Question addressed to the patient:How satisfied are you with the course of the therapy?

very satisfied satisfied less satisfied not satisfied

• First results, dermatologists

LOYON® survey• First results, dermatologists

LOYON® survey

• First results, dermatologists

LOYON® survey

• First results, dermatologists

LOYON® survey87% oF PATIEnTS lIKED loyon

AFTERbEFoRE

Page 4: loyon: THE SAFE & MIlD PSoRIASIS KERATolyTIC · 2018-07-18 · PSoRIASIS KERATolyTIC 0844 415 2420 info@purpleorchidpharma.com 95% of responding patients successfully treated within

LOYON® - Usage

Liquid, for external use onlyApplication directly to the dry skin

Massage in gentlyAt least 3 h, even over night

Remove with mild washing lotion

Repeat if needed,1x daily, 3 – 7 days

InDIvIDuAl: loyonLOYON comes in a 15ml bottle for cradle cap and a 50ml bottle with a spray nozzle and a dropper which can both be screwed into the top.The dropper makes it easy

to deliver the solution to a small or hard-to-reach area.If there are many plaques

on the scalp, it can be better to use the spray so that it can deliver droplets to cover it.For applying to a wider

zone such as knees and elbows where plaques commonly form, the spray is most effective.

1. Apply directly on to the skin using the spray or the dropper

2. Massage in gently then leave for at least three hours, or overnight

3. Remove with a mild wash

4. Repeat as needed, once daily for 3-7 days.

You should leave at least three hours before secondary treatments such as topical steroids are used. In practice, many people

apply LOYON at night and leave it overnight, then show-er and use a second treat-ment in the morning, or do it the other way around and apply LOYON in the morn-ing. There is no need to wash off

LOYON as it is non-toxic and mild, but as the plaques are loosened they tend to wash off in the shower.

0844 415 2420

[email protected]

www.loyon.co.uk

3h

1 Jacobi et al, Dermatol Ther (Heidlelb), DOI 10.1007-015-0068-3 January 2015. 2 Jacobi A, Mayer A, Anastasiadou Z, Augustin M. Keratolytic activity of a novel topical dimeticone formulation (PB/LO-112) compared to 10% salicylic acid oil in patients with psoriasis capitis. 7th Interna-tional Congress Psoriasis: From Gene to Clinic; 2014 December 11-13; London, UK. 3 Single center, noninterventional clinical trial to assess the safety, efficacy and tolerability of a dimeticone-based medical device in facilitating the removal of scales after topical application in patients with psoriasis corpris or psoriasis capitis. Hengge, U; Roschmann, K; Candler H; Psoriasis:Targets and Therapy 2017:7 41-49 4 Danby et al, Pediatric Dermatology Vol 30, No 1, 42-50, 2013